Switch theme
Sign up to access all valuation multiples
AmoreG is a manufacturer of personal care products and cosmetics. The company manufactures, markets and trades of cosmetics, personal care goods, and other related products. It also provides skin evaluation services, which measures, dryness, pollutants, and sensitivity of the skin. The company’s products portfolio includes Creams, Toner and Fluids, Ampoule, Cleansing, Eye Care, Serum, Sun Care, Body Care, and Special Care.
1945
n/a
LTM Revenue $3.2B
LTM EBITDA $414M
$643M
Benchmark forward-looking revenue and EBITDA valuation multiples across generative AI, climate tech, semiconductors, online marketplaces, vertical SaaS and 220 more verticals.
Amorepacific Hldgs has a last 12-month revenue (LTM) of $3.2B and a last 12-month EBITDA of $414M.
In the most recent fiscal year, Amorepacific Hldgs achieved revenue of $3.1B and an EBITDA of $718M.
Amorepacific Hldgs expects next 12-month revenue of XXX and NTM EBITDA of XXX
See Amorepacific Hldgs valuation multiples based on analyst estimates| LTM | NTM | Last FY | FY 2025 | FY 2026 | FY 2027 | |
|---|---|---|---|---|---|---|
| Revenue | $3.2B | XXX | $3.1B | XXX | XXX | XXX |
| Gross Profit | $2.3B | XXX | $2.2B | XXX | XXX | XXX |
| Gross Margin | 72% | XXX | 72% | XXX | XXX | XXX |
| EBITDA | $414M | XXX | $718M | XXX | XXX | XXX |
| EBITDA Margin | 13% | XXX | 23% | XXX | XXX | XXX |
| EBIT | $229M | XXX | $181M | XXX | XXX | XXX |
| EBIT Margin | 7% | XXX | 6% | XXX | XXX | XXX |
| Net Profit | $365M | XXX | $183M | XXX | XXX | XXX |
| Net Margin | 11% | XXX | 6% | XXX | XXX | XXX |
| Net Debt | XXX | XXX | n/a | XXX | XXX | XXX |
Financial data powered by Morningstar, Inc.
As of May 30, 2025, Amorepacific Hldgs's stock price is KRW 23938 (or $17).
Amorepacific Hldgs has current market cap of KRW 2.15T (or $1.6B), and EV of KRW 884B (or $643M).
See Amorepacific Hldgs trading valuation data| EV | Market Cap | Price 1D | Price 1M | Price 3M | Price 12M | EPS |
|---|---|---|---|---|---|---|
| $643M | $1.6B | XXX | XXX | XXX | XXX | $1.93 |
Sign up to access valuation multiples like growth-adjusted P/E, next 12-month EV/Revenue, EBITDA multiples by industry and many more
Start Free TrialAs of May 30, 2025, Amorepacific Hldgs has market cap of $1.6B and EV of $643M.
Amorepacific Hldgs's trades at 0.2x EV/Revenue multiple, and 0.9x EV/EBITDA.
Equity research analysts estimate Amorepacific Hldgs's 2025E EV/Revenue multiple at XXX and 2025E EV/EBITDA multiple at XXX
Amorepacific Hldgs has a P/E ratio of 4.3x.
See valuation multiples for Amorepacific Hldgs and 12K+ public comps| LTM | NTM | Last FY | FY 2025 | FY 2026 | FY 2027 | |
|---|---|---|---|---|---|---|
| Market cap (current) | $1.6B | XXX | $1.6B | XXX | XXX | XXX |
| EV (current) | $643M | XXX | $643M | XXX | XXX | XXX |
| EV/Revenue | 0.2x | XXX | 0.2x | XXX | XXX | XXX |
| EV/EBITDA | 1.6x | XXX | 0.9x | XXX | XXX | XXX |
| EV/EBIT | 2.8x | XXX | 3.5x | XXX | XXX | XXX |
| EV/Gross Profit | 0.3x | XXX | n/a | XXX | XXX | XXX |
| P/E | 4.3x | XXX | 8.5x | XXX | XXX | XXX |
| EV/FCF | n/a | XXX | 3.3x | XXX | XXX | XXX |
Valuation data powered by FactSet, Inc. and Morningstar, Inc.
Access all public comps and forward-looking valuation multiples like EV/Revenue in 2025, based on equity research analyst estimates.
Start Free TrialAmorepacific Hldgs's last 12 month revenue growth is 8%
Amorepacific Hldgs's revenue per employee in the last FY averaged n/a, while opex per employee averaged n/a for the same period.
Amorepacific Hldgs's rule of 40 is 23% (metric relevant for SaaS companies only, counted as combined revenue growth rate and EBITDA margin).
Amorepacific Hldgs's rule of X is 32% (created by Bessemer, rule of X is another metric relevant for SaaS companies only, ~1.5x stronger vs. the traditional Rule of 40, counted as revenue growth rate multiplied by 2.5 plus EBITDA margin).
See operational valuation multiples for Amorepacific Hldgs and other 12K+ public comps| LTM | NTM | Last FY | FY 2025 | FY 2026 | FY 2027 | |
|---|---|---|---|---|---|---|
| Revenue Growth | 8% | XXX | 8% | XXX | XXX | XXX |
| EBITDA Margin | 13% | XXX | 23% | XXX | XXX | XXX |
| EBITDA Growth | 17% | XXX | 1% | XXX | XXX | XXX |
| Rule of 40 | 23% | XXX | 31% | XXX | XXX | XXX |
| Bessemer Rule of X | XXX | XXX | 32% | XXX | XXX | XXX |
| Revenue per Employee | XXX | XXX | n/a | XXX | XXX | XXX |
| Opex per Employee | XXX | XXX | n/a | XXX | XXX | XXX |
| S&M Expenses to Revenue | XXX | XXX | 36% | XXX | XXX | XXX |
| G&A Expenses to Revenue | XXX | XXX | n/a | XXX | XXX | XXX |
| R&D Expenses to Revenue | XXX | XXX | 2% | XXX | XXX | XXX |
| Opex to Revenue | XXX | XXX | 66% | XXX | XXX | XXX |
Valuation data powered by FactSet, Inc. and Morningstar, Inc.
Benchmark public comps and private revenue and EBITDA valuation multiples across GRC software, cloud infrastructure, DevOps, online marketplaces and so much more!
| EV/Revenue | EV/EBITDA | |||||
|---|---|---|---|---|---|---|
| 2025E | 2026E | 2027E | 2025E | 2026E | 2027E | |
| Acme United | XXX | XXX | XXX | XXX | XXX | XXX |
| EZZ Life Science | XXX | XXX | XXX | XXX | XXX | XXX |
| Live Verdure | XXX | XXX | XXX | XXX | XXX | XXX |
| Lavipharm | XXX | XXX | XXX | XXX | XXX | XXX |
| Sarantis Group | XXX | XXX | XXX | XXX | XXX | XXX |
| XXXXXXXX | XXX | XXX | XXX | XXX | XXX | XXX |
| XXXXXXXX | XXX | XXX | XXX | XXX | XXX | XXX |
Valuation data powered by FactSet, Inc.
Amorepacific Hldgs acquired XXX companies to date.
Last acquisition by Amorepacific Hldgs was XXXXXXXX, XXXXX XXXXX XXXXXX . Amorepacific Hldgs acquired XXXXXXXX for XXX (EV/Revenue multiple of XXX ).
See M&A valuation multiples| Acquired Company | EV | EV/Revenue | EV/EBITDA |
|---|---|---|---|
| XXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXX | XXX | XXX | XXX |
Sign up to see revenue and EBITDA valuation multiples for 60K+ M&A deals.
Start Free Trial| When was Amorepacific Hldgs founded? | Amorepacific Hldgs was founded in 1945. |
| Where is Amorepacific Hldgs headquartered? | Amorepacific Hldgs is headquartered in South Korea. |
| Who is the CEO of Amorepacific Hldgs? | Amorepacific Hldgs's CEO is Mr. Kyung-Bae Seo. |
| Is Amorepacific Hldgs publicy listed? | Yes, Amorepacific Hldgs is a public company listed on KRX. |
| What is the stock symbol of Amorepacific Hldgs? | Amorepacific Hldgs trades under 002790 ticker. |
| When did Amorepacific Hldgs go public? | Amorepacific Hldgs went public in 1973. |
| Who are competitors of Amorepacific Hldgs? | Similar companies to Amorepacific Hldgs include e.g. Acme United, EZZ Life Science, Live Verdure, Lavipharm. |
| What is the current market cap of Amorepacific Hldgs? | Amorepacific Hldgs's current market cap is $1.6B |
| What is the current revenue of Amorepacific Hldgs? | Amorepacific Hldgs's last 12 months revenue is $3.2B. |
| What is the current revenue growth of Amorepacific Hldgs? | Amorepacific Hldgs revenue growth (NTM/LTM) is 8%. |
| What is the current EV/Revenue multiple of Amorepacific Hldgs? | Current revenue multiple of Amorepacific Hldgs is 0.2x. |
| Is Amorepacific Hldgs profitable? | Yes, Amorepacific Hldgs is EBITDA-positive (as of the last 12 months). |
| What is the current EBITDA of Amorepacific Hldgs? | Amorepacific Hldgs's last 12 months EBITDA is $414M. |
| What is Amorepacific Hldgs's EBITDA margin? | Amorepacific Hldgs's last 12 months EBITDA margin is 13%. |
| What is the current EV/EBITDA multiple of Amorepacific Hldgs? | Current EBITDA multiple of Amorepacific Hldgs is 1.6x. |
Get access to always up-to-date, precisely categorized 70K+ public and private valuation multiples, across tech and beyond.
